524516
BACPHAR
Start SIP
Invest Now
Start SIP in BACPHAR
Bacil Pharma live price: ₹47.8. It opened at ₹48 vs previous close ₹46; intraday high/low: ₹48/₹44. The 50 & 200 DMA stand at ₹42.48/₹39.30.
Bacil Pharma Performance
- Low
- ₹44
- High
- ₹48
- 52 Week Low
- ₹27
- 52 Week High
- ₹51
- Open Price₹48
- Previous Close₹46
- Volume34,228
- 50 DMA₹42.48
- 100 DMA₹41.02
- 200 DMA₹39.30
Investment Returns
- Over 1 Month + 23.99%
- Over 3 Month + 16.76%
- Over 6 Month + 36.34%
- Over 1 Year + 20.46%
Smart Investing Starts Here Start SIP with Bacil Pharma for Steady Growth!
Bacil Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 93.1
- PEG Ratio
- 0.8
- Market Cap Cr
- 69
- P/B Ratio
- 2.6
- Average True Range
- 3.95
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 1.87
- RSI
- 56.83
- MFI
- 47.39
Bacil Pharma Financials
Bacil Pharma Technicals
EMA & SMA
Current Price
₹47.80
+
1.79
(3.89%)
- Bearish Moving Average 2
- Bullish Moving Average 14
- 20 Day
- ₹45.14
- 50 Day
- ₹42.48
- 100 Day
- ₹41.02
- 200 Day
- ₹39.30
Resistance and Support
46.21
- R3 52.99
- R2 50.50
- R1 48.70
- S1 44.41
- S2 41.92
- S3 40.12
Bacil Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-13 | Quarterly Results | |
| 2025-11-13 | Quarterly Results | |
| 2025-09-05 | Others | Inter-alia, to consider 1. Fix Date, Place, Timing and Notice for 38th AGM of the Company. 2. Director Report of the Company for the Financial Year 2024-2025. 3. Other business matters. |
| 2025-08-25 | Others | Inter-alia, to consider 1. Discussion on Appointment of M/s Sarang Shivajirao Chavan & Associate as a Statutory Auditor of the Company. 2. Appointment of New Director. 3. Other business matters. |
| 2025-08-12 | Quarterly Results |
Bacil Pharma F&O
About Bacil Pharma
- NSE Symbol
- BACPHAR
- BSE Symbol
- 524516
- ISIN
- INE711D01018
Similar Stocks to Bacil Pharma
Bacil Pharma FAQs
Bacil Pharma share price is ₹47 As on 05 March, 2026 | 06:08
The Market Cap of Bacil Pharma is ₹68.6 Cr As on 05 March, 2026 | 06:08
The P/E ratio of Bacil Pharma is 93.1 As on 05 March, 2026 | 06:08
The PB ratio of Bacil Pharma is 2.6 As on 05 March, 2026 | 06:08
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.